Phibro Animal Health Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 833.35M | 942.26M | 977.89M | 1.02B | 1.30B | 27.4% | |
| Cost of Revenue | (561.97M) | (656.86M) | (679.65M) | (704.59M) | (896.27M) | 27.2% | |
Gross Profit | 271.38M | 285.40M | 298.24M | 313.09M | 399.94M | 27.7% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (196.51M) | (206.41M) | (226.39M) | (259.78M) | (289.48M) | 11.4% | |
| Depreciation & Amortization | (31.88M) | (32.70M) | (34.01M) | (36.18M) | (45.60M) | 26.1% | |
Operating Income (EBIT) | 74.87M | 78.99M | 71.85M | 53.31M | 110.47M | 107.2% | |
| Non-Operating Items | |||||||
| Interest Income | 838.00K | 816.00K | 3.35M | 4.47M | 2.62M | -41.4% | |
| Interest Expense | (10.40M) | (12.10M) | (17.95M) | (21.97M) | (33.25M) | 51.3% | |
| Other Income/Expenses (Net) | -8.40M | -6.66M | -17.78M | -42.40M | -42.47M | 0.2% | |
Income Before Tax | 66.47M | 72.33M | 54.07M | 10.92M | 67.99M | 522.9% | |
| Income Tax Expense | (12.08M) | (23.15M) | (21.46M) | (8.50M) | (19.73M) | 132.1% | |
Net Income | 54.38M | 49.17M | 32.61M | 2.42M | 48.26M | 1897.7% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $1 | $1 | $1 | $0 | $1 | 1883.3% | |
| Weighted Avg Shares Outstanding | 40.50M | 40.50M | 40.50M | 40.50M | 40.50M | -0.0% | |
| Weighted Avg Shares Outstanding (Diluted) | 40.50M | 40.50M | 40.50M | 40.52M | 40.70M | 0.4% | |
EBITDA | 110.21M | 117.13M | 106.03M | 69.06M | 146.85M | 112.6% |
Explore PAHC
PAHC in the Healthcare
Small Cap